• Clario accelerates your clinical trial from initiation to implementation. LEARN MORE →

Your using an unsupported browser. Please update to a modern browser for a better experience.
Skip to content
Clario
  • Solutions
    • eCOA Digital Solutions
      • eCOA Digital Solutions
      • eCOA Live
      • eCOA Multimedia
      • eCOA Rater and Participant Training
      • eCOA Rescue Studies
      • Suicidal Ideation
    • Cardiac Safety
      • Cardiac Safety
      • Arrhythmia Analysis
      • Blood Pressure Services
      • ECG — On-site to DCT and Phase I-IV
      • Phase I/TQT Cardiac Assessment
      • Regulatory Consultation and Statistical Analysis Expertise
    • Medical Imaging
      • Medical Imaging
      • Medical Imaging science team
      • FlexImaging
      • Image Redact AI
      • Image Repository
      • Imaging Platform
      • Image Workflow
      • Modalities
      • SMART Submit
    • Precision Motion
      • Precision Motion
      • Precision Motion: Scientific Consulting Services
      • Precision Motion: Scientific Publications
    • Respiratory Solutions
      • Respiratory Solutions
      • Cough and Lung Sounds
    • Trial Enablement
      • Trial Enablement
      • Clinical Adjudication
      • Clinical Trial Management
      • Electronic Data Capture (EDC)
      • Eligibility Solution
      • Payments
      • Randomization and trial supply management
      • Reporting & Analytics
      • Source Document Manager
    • Decentralized Trials
      • Decentralized Trials
      • eConsent
  • Therapeutic Areas
    • Cardiovascular & Metabolic
    • Dermatology
    • Gastroenterology
    • Hepatology
    • Infectious Diseases
    • Musculoskeletal
    • Neuroscience
    • Oncology
    • Ophthalmology
    • Respiratory Solutions
  • Resources
    • Articles
    • Case Studies
    • Downloads
    • Events
    • External Publications
    • Webinars
  • About
    • The Clario Story
    • Values & Culture
    • Security Governance
    • Corporate & Social Responsibility
    • Leadership
    • Scientific Expertise
    • Strategic Partnerships
    • Legal & Privacy
  • Support
  • Careers
    • Life at Clario
  • Newsroom
  • Login
  • Contact sales
    • Log in
    • Contact sales
  1. Home Resources Downloads Early precision QT

Early precision QT

Minimize risk and make smart decisions

Build confidence with more precise QT assessments

Clinical trials are becoming increasingly complex and study methodologies must evaluate a novel drug in a way that provides a reliable evaluation of its potential benefit. Innovations in cardiac safety assessments could allow for much earlier study of proarrhythmia risk, eliminating the need for costly Thorough QT (TQT) studies in the later stages of clinical trials.

Build confidence in your study data and eliminate risk by driving earlier, more precise QT assessments with Early Precision QT (EPQT). You could save millions in development costs and shorten time to market by getting more granular insights in the initial stage of your development pipeline.

Every millisecond of precision counts when assessing cardiac safety

Obtain highly precise ECG data

Cardiac Technologies, acquired by Clario in late 2017, formulated the transformative EPQT methodology for obtaining highly-precise ECG data, which was developed in collaboration with industry-leading cardiac safety experts, pharmaceutical researchers, the FDA and IQCSRC. The EPQT methodology was clinically proven in a comprehensive clinical trial, which concluded that ECGs collected and analyzed during routine early-phase studies could reliably provide cardiac safety information typically derived from dedicated TQT studies. Confidently implement EPQT in your Phase 1 studies to enable earlier, more precise and cost-effective cardiac safety assessments and potentially qualify for a TQT waiver.

Potentially save millions in TQT study costs while obtaining reliable data earlier in development

EPQT drives earlier, more precise QT assessments, at lower cost

Conduct early assessments and comply with regulatory changes

Manage your pipelines more efficiently by enabling earlier product launch and ensuring promising drugs aren’t inappropriately eliminated due to inaccurate cardiac safety data.

Minimize risk early and save resources

In addition to saving precious time and resources, precise QT assessments early in your study can lead to relaxed QT inclusion criteria, which improves patient enrollment. This actionable QT data can be leveraged for out-licensing and improved pipeline prioritization.

Increase confidence with science and expertise

Boost confidence in your trial results by letting our Phase 1 QT Center of Excellence guide you from protocol through final report. Improve data quality and precision with tools that blend the best of technology and medical expertise. We have more Phase 1 QT experience than any other ECG lab in the world — experience gained across 3,600+ Phase 1 cardiac safety trials.

Get precise anticipatory oversight

Ensure the reliability of your early-phase QT assessment with our proprietary Method Bias Sensitivity (MBS) analysis, built and scientifically validated over many trials. With MBS, regulators will have certainty that the ECG core lab has not introduced bias into test results.

Minimize risk and make smart decisions.

Talk to a specialist
Download
Back to downloads
Share
Twitter Facebook LinkedIn

Latest Downloads

See all
Presentation

Practical respiratory insights on the latest spirometry guidelines and asthma clinical trials

Download icon Download icon
Download
Presentation

Fulfilling cardiac safety requirements without a Thorough QT study

Download icon Download icon
Download
Brochure

Strados Labs’ RESP™ Biosensor for Clinical Trials

Download icon Download icon
Download
Datasheet

iSpiro – Next generation respiratory home monitoring

Read icon Read icon
Read
Clario logo
    • Solutions
    • Therapeutic Areas
    • About
    • Resources
    • Careers
    • News
  • Get in touch

    • Contact
    • Support
    • Customer portal

Follow us

Twitter LinkedIn Glassdoor
×

Contact sales

If you are looking for a partner to help you generate the richest clinical evidence with the right clinical trial technology, please fill in the form below or send us an email.

Customer support

Questions regarding your clinical trial technology or need technical support? Our customer care teams are ready to help you.

Customer support

Media contact

If you would like to speak with one of our innovators or thought leaders, connect with our public relations team.

Email: [email protected]

Our Locations

View our locations

Thanks for your form. Our team will be in touch very soon.

  • © 2023 Clario

    • Legal and Privacy Terms
    • Security Governance
    • Cookie Policy
    • Impressum

Please enter your business email before proceeding to xTalks to complete registration.

×